当前位置:
X-MOL 学术
›
Nat. Rev. Cancer
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Bidirectional CART.BiTE cells bring new hope
Nature Reviews Cancer ( IF 72.5 ) Pub Date : 2022-02-02 , DOI: 10.1038/s41568-022-00451-8 Guiqin Xie 1, 2 , Xinbin Gu 1, 2
Nature Reviews Cancer ( IF 72.5 ) Pub Date : 2022-02-02 , DOI: 10.1038/s41568-022-00451-8 Guiqin Xie 1, 2 , Xinbin Gu 1, 2
Affiliation
Xie and Gu discuss a study that reported the development of a CAR T therapy-based multi-antigen targeting strategy for the treatment of glioblastoma (GBM) in mice, overcoming antigen specificity and heterogeneity.
中文翻译:
双向CART.BiTE细胞带来新希望
谢和顾讨论了一项研究,该研究报告了一种基于 CAR T 疗法的多抗原靶向策略的开发,用于治疗小鼠胶质母细胞瘤 (GBM),克服了抗原特异性和异质性。
更新日期:2022-02-03
中文翻译:
双向CART.BiTE细胞带来新希望
谢和顾讨论了一项研究,该研究报告了一种基于 CAR T 疗法的多抗原靶向策略的开发,用于治疗小鼠胶质母细胞瘤 (GBM),克服了抗原特异性和异质性。